Ambulnz, Inc. and Subsidiaries CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIODS ENDED SEPTEMBER 30, 2021 and 2020 Condensed Consolidated Balance Sheets as of

Ambulnz, Inc. and Subsidiaries

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE PERIODS ENDED SEPTEMBER 30, 2021 and 2020

Ambulnz, Inc. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

The accompanying notes are an integral part of

these Condensed Consolidated Financial statements.

Ambulnz, Inc. and Subsidiaries

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS

COMPREHENSIVE INCOME (LOSS)

The accompanying notes are an integral part of

these Condensed Consolidated Financial statements.

Ambulnz, Inc. and Subsidiaries

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS

OF CHANGES IN STOCKHOLDERS' EQUITY

The accompanying notes are an integral part of

these Condensed Consolidated Financial statements.

Ambulnz, Inc. and Subsidiaries

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS

The accompanying notes are an integral part of

these Condensed Consolidated Financial statements.

Ambulnz, Inc. and Subsidiaries

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS

OF CASH FLOWS (CONTINUED)

The accompanying notes are an integral part of

these Condensed Consolidated Financial statements.

Ambulnz, Inc. and Subsidiaries

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL

Ambulnz, LLC was originally formed in Delaware

on June 17, 2015, as a limited liability company. On November 1, 2017, with an effective date of January 1, 2017, Ambulnz converted its

legal structure from a limited liability company to a C-corporation and changed its name to Ambulnz, Inc. ("Ambulnz"). Ambulnz

is the sole owner of Ambulnz Holdings, LLC ("Holdings") which was formed in the state of Delaware on August 5, 2015, as a limited

liability company. Holdings is the owner of multiple operating entities incorporated in various states in the United States as well as

within England and Wales, United Kingdom.

Ambulnz, Inc. and Subsidiaries (collectively,

the "Company") is a healthcare transportation and Mobile Health services company ("Mobile Health") that uses proprietary

dispatch and communication technology to provide quality healthcare transportation and healthcare services in major metropolitan cities

in the United States and the United Kingdom. Mobile Health performs in-person care directly to patients in the comfort of their homes,

workplaces and other non-traditional locations.

On March 8, 2021, Motion Acquisition Corp., ("Motion"),

entered into a Merger Agreement ("Merger Agreement") by and among Motion, Motion Merger Sub Corp. and a wholly owned subsidiary

of Motion ("Merger Sub"), and Ambulnz, Inc. ("Ambulnz"). Pursuant to the Merger Agreement, the parties will enter

into a business combination transaction by which Merger Sub will merge with and into the Ambulnz ("Merger"), with Ambulnz

being the surviving entity of the Merger and becoming a wholly-owned subsidiary of Motion. Concurrent with the consummation of the Merger,

(i) each option and warrant of Ambulnz that is outstanding and unexercised ("Convertible Securities") immediately prior to

the effective time of the Merger ("Effective Time") will be assumed by Motion and will represent the right to acquire an adjusted

number of shares of Motion Common Stock at an adjusted exercise price, (ii) the outstanding shares of preferred stock of Ambulnz issued

and outstanding immediately prior to the Effective Time will be converted into shares of Class A common stock of Ambulnz, in each case,

pursuant to the terms of the Merger Agreement. The Company's Equity, on a fully diluted basis, will be converted into 83.6 million

shares of Class A common stock of Motion (excluding 5.0 million additional shares subject to earnout provisions) at a price of $10.00

per share (the "Transaction Shares").

2. Summary of Significant Accounting Policies

Basis of Presentation

We have prepared the accompanying financial data

as of September 30, 2021, the interim results for the quarter and nine months ended September 30, 2021 are not necessarily indicative

of results for the full 2021 calendar year or any other future interim periods, without audit, pursuant to the rules and regulations of

the U.S. Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial

statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed

or omitted pursuant to such rules and regulations. The December 31, 2020 Consolidated Balance Sheet was derived from audited financial

statements, but does not include all disclosures required by accounting principles generally accepted in the United States. However, we

believe that the disclosures are adequate to make the information presented not misleading. These Consolidated Financial Statements should

be read in conjunction with the Consolidated Financial Statements and the notes thereto included in the form S-4. Noncontrolling interests

("NCI") on the consolidated statements of financial condition represents the portion of consolidated joint ventures and a

variable interest entity in which the Company does not have direct equity ownership. Accounts and transactions between consolidated entities

have been eliminated.

Principles of Consolidation

The accompanying Condensed Consolidated Financial

statements include the accounts of Ambulnz and its subsidiaries. All significant intercompany transactions and balances have been eliminated

in these Condensed Consolidated Financial Statements.

Ambulnz, Inc. and Subsidiaries

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL

STATEMENTS (CONTINUED)

The Company holds a variable interest which contracts

with physicians and other health professionals in order to provide services to the Company. MD1 Medical Care P.C. ("MD1")

is considered a variable interest entity ("VIE") since it does not have sufficient equity to finance its activities without

additional subordinated financial support. An enterprise having a controlling financial interest in a VIE must consolidate the VIE if

it has both power and benefits-that is, it has (1) the power to direct the activities of a VIE that most significantly impacts

the VIE's economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant

to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has

the power and rights to control all activities of MD1 and funds and absorbs all losses of the VIE and appropriately consolidates Ambulnz,

Inc. and Subsidiaries.

Total revenue for the three and nine months period

for the VIE amounted to $337,654 at September 30, 2021. Net loss for the three and nine months period for the VIE was $321,079 at September

30, 2021. The VIE's total assets, all of which were current, was $220,081 at September 30, 2021. Total liabilities, all of which

were current for the VIE, was $189,167 at September 30, 2021. The VIE's total stockholders' equity was $30,914 at September

The Company's functional currency is the

U.S. dollar. The functional currency of our foreign operation is the respective local currency. Assets and liabilities of foreign operations

denominated in local currencies are translated at the spot rate in effect at the applicable reporting date, except for equity accounts

which are translated at historical rates. The consolidated statements of operations are translated at the weighted average rate of exchange

during the applicable period. The resulting unrealized cumulative translation adjustment is not material to the financial statements.

The preparation of financial statements requires

management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of

contingent assets and liabilities in its financial statements and the reported amounts of expenses during the reporting period. The most